85 related articles for article (PubMed ID: 24589329)
1. Automated tests of ANA immunofluorescence as throughput autoantibody detection technology: strengths and limitations.
Meroni PL; Bizzaro N; Cavazzana I; Borghi MO; Tincani A
BMC Med; 2014 Mar; 12():38. PubMed ID: 24589329
[TBL] [Abstract][Full Text] [Related]
2. Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.
Sowa M; Hiemann R; Schierack P; Reinhold D; Conrad K; Roggenbuck D
Clin Rev Allergy Immunol; 2017 Aug; 53(1):87-104. PubMed ID: 27368807
[TBL] [Abstract][Full Text] [Related]
3. Adopting the International Consensus on ANA Patterns (ICAP) classification for reporting: the experience of Italian clinical laboratories.
Infantino M; Bizzaro N; de Melo Cruvinel W; Chan EKL; Andrade LEC
Clin Chem Lab Med; 2024 Apr; 62(5):830-834. PubMed ID: 37852014
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and sociodemographic correlates of antinuclear antibody testing by indirect immunofluorescence or solid-phase assays in a Spanish population: the Camargo Cohort.
Irure-Ventura J; Martínez-Revuelta D; López-Hoyos M; Martín-Millán M; Nan D; Pariente E; Pardo-Lledías J; Comins-Boo A; Olmos JM; Martínez-Taboada VM; Hernández JL
Immunol Res; 2024 Apr; 72(2):260-270. PubMed ID: 37924421
[TBL] [Abstract][Full Text] [Related]
5. Recognition of rare antinuclear antibody patterns based on a novel attention-based enhancement framework.
Zeng J; Gao X; Gao L; Yu Y; Shen L; Pan X
Brief Bioinform; 2024 Jan; 25(2):. PubMed ID: 38279651
[TBL] [Abstract][Full Text] [Related]
6. Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.
Mahler M; Meroni PL; Bossuyt X; Fritzler MJ
J Immunol Res; 2014; 2014():315179. PubMed ID: 24868563
[TBL] [Abstract][Full Text] [Related]
7. A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies.
Shovman O; Agmon-Levin N; Gilburd B; Martins T; Petzold A; Matthias T; Shoenfeld Y
Immunol Res; 2015 Feb; 61(1-2):135-40. PubMed ID: 25403695
[TBL] [Abstract][Full Text] [Related]
8. Second generation analysis of antinuclear antibody (ANA) by combination of screening and confirmatory testing.
Scholz J; Grossmann K; Knütter I; Hiemann R; Sowa M; Röber N; Rödiger S; Schierack P; Reinhold D; Bogdanos DP; Meroni PL; Radice A; Conrad K; Roggenbuck D
Clin Chem Lab Med; 2015 Nov; 53(12):1991-2002. PubMed ID: 26020561
[TBL] [Abstract][Full Text] [Related]
9. The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases.
Satoh M; Tanaka S; Chan EK
Front Immunol; 2015; 6():181. PubMed ID: 25954274
[No Abstract] [Full Text] [Related]
10. How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit.
Hira-Kazal R; Shea-Simonds P; Peacock JL; Maher J
Clin Exp Immunol; 2015 Apr; 180(1):52-7. PubMed ID: 25412573
[TBL] [Abstract][Full Text] [Related]
11. An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management.
Ameer MA; Chaudhry H; Mushtaq J; Khan OS; Babar M; Hashim T; Zeb S; Tariq MA; Patlolla SR; Ali J; Hashim SN; Hashim S
Cureus; 2022 Oct; 14(10):e30330. PubMed ID: 36407159
[TBL] [Abstract][Full Text] [Related]
12. A 3D mixing-based portable magnetic device for fully automatic immunofluorescence staining of γ-H2AX in UVC-irradiated CD4
Zhong R; Hou L; Zhao Y; Wang T; Wang S; Wang M; Xu D; Sun Y
RSC Adv; 2020 Aug; 10(49):29311-29319. PubMed ID: 35521108
[TBL] [Abstract][Full Text] [Related]
13. Properties of Uncommon Indirect Immunofluorescence Staining Patterns Determined during Antinuclear Antibody Detection on HEp-2 Cells.
Tomić Sremec N; Kozmar A; Sremec J; Anić B; Batinić D
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501315
[TBL] [Abstract][Full Text] [Related]
14. Standardization and Quality Assessment Under the Perspective of Automated Computer-Assisted HEp-2 Immunofluorescence Assay Systems.
Cinquanta L; Bizzaro N; Pesce G
Front Immunol; 2021; 12():638863. PubMed ID: 33717188
[TBL] [Abstract][Full Text] [Related]
15. Performance analysis of automated evaluation of antinuclear antibody indirect immunofluorescent tests in a routine setting.
van Beers JJBC; Hahn M; Fraune J; Mallet K; Krause C; Hormann W; Fechner K; Damoiseaux JGMC
Auto Immun Highlights; 2018 Sep; 9(1):8. PubMed ID: 30238164
[TBL] [Abstract][Full Text] [Related]
16. Automated Processing and Evaluation of Anti-Nuclear Antibody Indirect Immunofluorescence Testing.
Ricchiuti V; Adams J; Hardy DJ; Katayev A; Fleming JK
Front Immunol; 2018; 9():927. PubMed ID: 29780386
[TBL] [Abstract][Full Text] [Related]
17. Recent Approaches To Optimize Laboratory Assessment of Antinuclear Antibodies.
Tebo AE
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021301
[TBL] [Abstract][Full Text] [Related]
18. Automated evaluation of ANA under real-life conditions.
Loock CD; Egerer K; Feist E; Burmester GR
RMD Open; 2017; 3(1):e000409. PubMed ID: 28848653
[TBL] [Abstract][Full Text] [Related]
19. Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study.
Akmatov MK; Röber N; Ahrens W; Flesch-Janys D; Fricke J; Greiser H; Günther K; Kaaks R; Kemmling Y; Krone B; Linseisen J; Meisinger C; Moebus S; Obi N; Guzman CA; Conrad K; Pessler F
Arthritis Res Ther; 2017 Jun; 19(1):127. PubMed ID: 28587625
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
